Thursday, June 2, 2022 Daily Archives

With US Gov contract, Evonik ploughs $220m into Indiana lipid plant

by

Evonik’s lipid manufacturing facility in Lafayette, Indiana will service demand from the Biomedical Advanced Research and Development Authority (BARDA) for mRNA-based therapies beyond COVID-19 vaccines. Evonik’s second largest site in the US will benefit from a lipid manufacturing facility. Construction is set to begin in early 2023, with the plant expected to be operational by 2025. Of the $220 million being invested in Tippecanoe, $150 million will come from the US Department of Health and Human Services (HHS) division BARDA…

June 2, 2022

Regeneron to supply Elicio with Libtayo for combo cancer vaccine study

by

Regeneron has agreed to supply Elicio Therapeutics with the drug Libtayo for clinical trials of its candidate cancer vaccine, ELI-002. The trial will examine the products as a combination in patients with KRAS (Kirsten rat sarcoma virus)-driven tumors including stage III and IV non-small cell lung cancer, stage IV colorectal cancer and unresectable, locally advanced or oligometastatic pancreatic ductal adenocarcinoma. KRAS mutations are among the most prevalent human cancers, driving 32% of lung cancers, 40% of colorectal cancers and 85%…

June 2, 2022